Biotek-snakken — Marts 2023
-
Bioporto overvejer kapitaludvidelse på 75 mio. kr. https://www.proinvestor.com/investornyt/955418/bioporto-overvejer-kapitaludvidelse-pa-75-mio-kr
-
Xbrane præsentation på investor day… https://www.biostock.se/investormeetingmarch23/
-
Videoopdatering - Denne uge fokuserer Helge Larsen på Zealand Pharma, som netop har haft Q&A på ProInvestor. https://www.proinvestor.com/boards/111438
-
2 Biotech Stocks To Watch In March 2022
https://www.proinvestor.com/investornyt/955946/2-biotech-stocks-to-watch-in-march-2022 -
3 (Good) Reasons Warren Buffett Doesn't Invest in Biotech Stocks https://www.proinvestor.com/investornyt/956745/3-good-reasons-warren-buffett-doesnt-invest-in-biotech-stocks
-
Xbrane opdatering af Pareto. Kursmål 275.00 (kurs p.t. ca. 80.00) Hør fra kl. 12.25 på linket: https://www.youtube.com/watch?v=c67ph6zj6Ao&ab_channel=DirektStudios
-
Ja, Urban….XBrane er en spændende case, med “minimal” risiko, da det er biosimilarer og ikke “normal” biotek som har MEGET højere risiko. XBrane forventer grøn bundlinje i 2024, og har penge i kassen nu. Partner aftaler kan også være en stor kurs trigger. Fatter ikke den ligger og roder under kurs 100, men et nervøst marked banker den ned hver gang den stiger.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind